Fluidigm Corporation  

(Public, NASDAQ:FLDM)   Watch this stock  
Find more results for FLDM
-0.28 (-4.08%)
Feb 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.57 - 6.89
52 week 4.31 - 11.05
Open 6.89
Vol / Avg. 0.00/218,272.00
Mkt cap 184.07M
P/E     -
Div/yield     -
EPS -2.62
Shares 29.12M
Beta 3.16
Inst. own 102%
Feb 2, 2017
Q4 2016 Fluidigm Corp Earnings Release (Estimated)
Nov 30, 2016
Fluidigm Corp at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin -70.55% -72.75%
Operating margin -70.55% -70.07%
EBITD margin - -52.90%
Return on average assets -22.65% -22.47%
Return on average equity -117.13% -90.39%
Employees 584 -
CDP Score - -


7000 Shoreline Ct Ste 100
United States - Map
+1-650-2666000 (Phone)
+1-650-8717152 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

Officers and directors

Samuel D. Colella Independent Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Stephen Christopher Linthwaite President, Chief Executive Officer, Chief Operating Officer, Director
Age: 45
Bio & Compensation  - Reuters
Vikram Jog Chief Financial Officer
Age: 59
Bio & Compensation  - Reuters
William Maxwell Smith J.D. Executive Vice President - Legal Affairs, General Counsel, Secretary
Age: 65
Bio & Compensation  - Reuters
Robert C. Jones Executive Vice President - Research and Development
Age: 60
Bio & Compensation  - Reuters
Jennifer Ling Lee Principal Accounting Officer, Vice President, Controller
Age: 53
Bio & Compensation  - Reuters
Mai Chan Yow Executive Vice President - Worldwide Manufacturing and Managing Director
Age: 56
Bio & Compensation  - Reuters
Gerhard F. Burbach Independent Director
Age: 53
Bio & Compensation  - Reuters
Evan Jones Independent Director
Age: 59
Bio & Compensation  - Reuters
Patrick Schwager Jones Independent Director
Age: 70
Bio & Compensation  - Reuters